Blog

Next-generation sequencing (NGS) has revolutionized science, but the quality of the results depends on one essential step: library preparation. Revvity's NEXTFLEX™ kits combine flexibility, precision, and efficiency to transform DNA or RNA into sequencing-ready libraries, even from minimal sample amounts. From gene expression studies to metagenomic analyses, their optimized reagents ensure reproducible, high-quality data in any NGS workflow.

Magnetic beads have quietly transformed molecular biology. Behind many advances in research and diagnostics lies their ability to purify DNA and RNA quickly, cleanly, and automatically. Today, technologies like Revvity's chemagic™, distributed in Spain by Proquinorte, represent the most advanced evolution of this principle: optimized chemistry that combines greater purity, speed, and reliability in nucleic acid purification.

For decades, ELISA has been the standard for quantifying proteins, antibodies, and antigens. However, modern biology—especially the field of biotherapeutics and recombinant proteins—demands more sensitive, reproducible methods that are compatible with high-volume analysis.

Each season, outbreaks of respiratory infections pose a considerable challenge to healthcare systems. The similarity of symptoms between diseases such as influenza, COVID-19, and respiratory syncytial virus (RSV) makes it difficult to accurately identify the causative agent, especially in the early days of infection. In this context, rapid and reliable diagnosis becomes an essential tool for making appropriate clinical decisions, reducing transmission, and optimizing hospital resources.

During the winter season, respiratory infections increase, and distinguishing between influenza, COVID-19, and RSV becomes a clinical challenge. Although the symptoms are similar, each virus requires a different diagnostic approach. In this article, we explain the main differences between these pathogens, the importance of molecular diagnostics, and how multiplex kits allow for the detection of several respiratory viruses in a single test, ensuring rapid and reliable results for more precise care.

Each year, influenza viruses undergo small mutations that complicate their detection and control. Therefore, laboratories need updated diagnostic kits that guarantee reliable results against the latest influenza strains. In this article, we explain why influenza is constantly changing, how the viruses adapt, and what advancements new detection kits incorporate to maintain their accuracy throughout flu season.

Learn about the main international biosafety regulations that guarantee the safety of your laboratory and discover why choosing a certified biosafety cabinet makes all the difference.

Choosing the right biosafety cabinet is key to ensuring protection, regulatory compliance, and efficiency in the laboratory. In this article, we give you the keys to identifying which model best suits your needs.

Is it possible to reduce a laboratory's environmental footprint without compromising biosafety? Discover how BIO II STANDARD biosafety cabinets combine safety, sustainability, and energy efficiency in a single unit.

The accurate detection and quantification of the BCR-ABL1 p210 and p190 isoforms is crucial for the diagnosis, monitoring, and treatment of Ph+ leukemias. HoopBio, through dPCR technology, offers innovative solutions that increase sensitivity, accuracy, and traceability in molecular diagnostic laboratories, facilitating disease monitoring and personalized medicine.